|
Pharmalink AB Receives Patent for Nefecon(R) Principle - SYS-CON Media (press release) |
|
|
|
SYS-CON Media (press release)... for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). ...
|